ArticleBMC ophthalmology2014

Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.

Kaidi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.